Dr. Sainath Bhethanabhotla
DesignationSenior Consultant
SpecialtyMedical Oncologist
Experience 19 years of experience
Languages SpokenEnglish, Hindi, Telugu
About Dr. Sainath Bhethanabhotla
- Dr. Sainath Bhethanabhotla is a Senior Consultant and Head of Medical Oncology with expertise in cancer care and hematological malignancies.
- He has extensive experience in pediatric and adult oncology with a strong focus on evidence-based treatment protocols.
- He is associated with leading hospitals in Hyderabad including CARE Hospitals and Krishna Institute of Medical Sciences.
- He has significant academic and research contributions in oncology published in reputed international journals.
Specializations & Conditions Treated
Immunotherapy
Chemotherapy
Radiation Therapy
Proton Therapy
Targeted Therapy
Education
MBBS
MD
DM
Work Experience of Dr. Sainath Bhethanabhotla
Dr. Sainath Bhethanabhotla has worked at MNJ Institute of Oncology and Regional Cancer Centre.
He has served at Krishna Institute of Medical Sciences, Hyderabad.
He is currently working at CARE Hospitals, Hyderabad and Soumya Hospitals, Hyderabad.
He has extensive experience in pediatric oncology and medical oncology practice.
Awards & Recognition
He received the Sorel Catherine Prize for Best Postgraduate in Pediatrics.
He secured 2nd position in NNF Gold Medal Paper in 2012.
He received a scholarship for oral presentation at SIOP 2015.
He was awarded the Abstract Achievement Award at the American Society of Hematology Meeting in 2017.
Publications
Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, et al. Post-treatment PET-CT Rather than Interim PET-CT Using Deauville criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: a Prospective Study Comparing PET-CT versus Conventional Imaging. J Nucl Med. 2016 Oct 6; (IMPACT FACTOR – 10.06)
Bhethanabhotla S, Bakhshi S. Presence of risk factors does not affect outcome in early-stage pediatric Hodgkin lymphoma treated with ABVD. Ann Hematol. 2016 Nov 18; (IMPACT FACTOR – 3.63)
Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, et al. Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients. Leuk Lymphoma. 2016 Dec 6;1–7. (IMPACT FACTOR – 2.99)
Bhethanabhotla S, Bakhshi S. Reply: Neither post-treatment PET-CT nor interim PET-CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma. J Nucl Med. 2016 Dec 8; (IMPACT FACTOR – 10.06)
Bhethanabhotla S, Tiwari A, Sharma MC, Vishnubhatla S, Bakhshi S. Prognostic Significance of IL-6 in Hodgkin Lymphoma. Indian J Pediatr. 2019 June 1;86(6):551–4. (IMPACT FACTOR – 1.96)
Mittal A, Bhethanabhotla S, Ganguly S, Vishnubhatla S, Khadgawat R, Patel C, et al. Late effects in pediatric Hodgkin lymphoma survivors after uniform treatment with ABVD with or without radiotherapy. Pediatr Blood Cancer. 2021 Nov;68(11):e29293. (IMPACT FACTOR – 3.16)
Bhethanabhotla S, Pramanik R, Srivastava P, Mehta P, Patel A, Biswas B, et al. Colorectal Cancer Chemotherapy during COVID-19 Pandemic. Indian J Med Paediatr Oncol. 2020 Mar;41(2):156–60.
Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect of position of infant during phototherapy in management of hyperbilirubinemia in late preterm and term neonates: a randomized controlled trial. J Perinatol. 2013 Oct;33(10):795–9. (IMPACT FACTOR – 2.52)
Our website uses cookies. By clicking on accept you give your consent to the use of cookies as per our Privacy Policy.